What we do
About our project
Medication management for patients in the last phase of life is regularly underperformed. Many symptoms contributing to the quality of life are often underreported and about 83-97% of the patients use multiple potentially inappropriate medications (PIMs). Medications can become potentially inappropriate due to, for example, changed treatment objectives because of a limited life expectancy. Up to now, few research have been done to the discontinuation of medication and overall symptom management in patients in the last phase of life.
The iLIVE medication study is an international, multicentre, uncontrolled before-after study in which a clinical decision support system (CDSS) generates alerts on medication management. The aim of the study is to examine whether the use of the CDSS contributes the quality of life of patients and if it contributes to create awareness among physicians and support them in medication management. The medication alerts are based on scientific literature, currently available guidelines and pharmacological insights. This study is part of a larger international cohort study, the iLIVE project, which investigates the concerns, expectations and preferences for care of patients with a limited life expectancy and their relatives.
The iLIVE medication study is an international, multicentre, uncontrolled before-after study in which a clinical decision support system (CDSS) generates alerts on medication management. The aim of the study is to examine whether the use of the CDSS contributes the quality of life of patients and if it contributes to create awareness among physicians and support them in medication management. The medication alerts are based on scientific literature, currently available guidelines and pharmacological insights. This study is part of a larger international cohort study, the iLIVE project, which investigates the concerns, expectations and preferences for care of patients with a limited life expectancy and their relatives.
Our research focus
- Patients’ quality of life
- Palliative Care
- Medication Optimization
- Potentially inappropriate medication
- Clinical Decision Support System
Funds & Grants
This project is supported by the European Union Horizon2020 program.
Collaborations
Collaborations within the Erasmus MC
- Department of Public health, research group: medical decisions in end-of-life care
- Department of pulmonology: Longgeneeskunde Erasmus MC
Collaborations outside of Erasmus MC
- Amsterdam UMC: Amsterdam UMC, Locatie VUmc - Medische oncologie
- Hospice Calando: Hospice Calando, Vivaldilaan 2-4, 3247 EE Dirksland, www.calando.nl
- Hospice Kuria: Kuria – hospice in Amsterdam
- PaTZ groep Kralingen
International collaboration
- Switzerland
- Sweden
Our team
- Carin van der Rijt
- Eric Geijteman
- Agnes van der Heide
- Hugo van der Kuy
- Iris Pot
- Marte van Hylckama Vlieg
